Pharmaceuticals

Vaccine Adjuvants Market 2026 projected to reach $3.13 billion by 2030

March 25, 2026March 25, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Vaccine Adjuvants Market Expected To Change Between 2026 And 2030?

The vaccine adjuvants market has experienced significant growth in recent years. Projections indicate its expansion from $2.01 billion in 2025 to $2.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.4%. This historical growth is attributable to factors such as the increasing spread of infectious diseases, heightened government investment in vaccine research, the wider acceptance of conventional vaccines, the creation of oil-in-water and water-in-oil emulsion technologies, and innovations in pathogen component adjuvants.

The vaccine adjuvants market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $3.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. The anticipated growth during this period stems from factors such as increasing demand for both human and animal vaccines, a heightened emphasis on immunotherapies for cancer and infectious diseases, advancements in nanoparticle and liposome-based adjuvants, favorable regulatory frameworks for new adjuvants, and the expansion of biologics production facilities. Key trends expected in the forecast include the development of personalized vaccine adjuvants, the emergence of new immunostimulatory compounds, adjuvants designed to target multiple diseases, improved safety and effectiveness profiles, and platforms for rapid vaccine formulation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Which Major Factors Are Driving The Expansion Of The Vaccine Adjuvants Market?

Increased investment in vaccine research activities is expected to drive the expansion of the vaccine adjuvants market. These activities encompass extensive scientific endeavors aimed at creating, evaluating, and improving vaccines to prevent infectious diseases. Such research plays a critical role in developing, testing, and optimizing potential adjuvant candidates sourced from various origins, including natural products, synthetic compounds, and even bacteria or viruses. For instance, in October 2023, the United States Department of Health and Human Services, a US-based provider of essential human services, announced Project NextGen with a $500 million investment to commence the development of phase 2b clinical trial plans and technologies for cutting-edge next-generation vaccination and treatment platforms. Therefore, the rising funding for vaccine research activities is propelling the growth of the vaccine adjuvants market.

How Is The Vaccine Adjuvants Market Structured Across Different Segments?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Which Trends Are Shaping The Future Of The Vaccine Adjuvants Market?

Leading companies in the vaccine adjuvants market are concentrating on technological advancements, such as cultured-plant-cell QS-21 (cpcQS-21), to address the increasing demand for sustainable and scalable production of potent immune-stimulating adjuvants. QS-21 is a powerful saponin adjuvant traditionally extracted from the bark of Quillaja saponaria trees; unlike conventional aluminum-based adjuvants, QS-21 provokes both strong antibody and cellular immune responses, though its supply faces limitations due to bark scarcity and quality variations. In August 2024, SaponiQx, a US-based biomanufacturing company, introduced STIMULON cultured plant cell QS-21, a cpcQS-21 adjuvant, made available for commercial acquisition through InvivoGen. This product is manufactured using plant cell culture instead of tree bark, ensuring a consistent and scalable supply; it provides high purity, lot-to-lot uniformity, and a reduced environmental impact. Functionally, STIMULON cpcQS-21 exhibits the same immunostimulatory potency as tree-derived QS-21 in stimulating both humoral and cellular immune responses, making it suitable for application in vaccines for infectious diseases like malaria, shingles, and RSV.

Which Major Players Dominate The Vaccine Adjuvants Market?

Major companies operating in the vaccine adjuvants market are GlaxoSmithKline Plc., Novavax Inc., Agenus Inc., CSL Limited, Adjuvatis, Merck KGaA, Seppic Inc., Virometix AG, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc.

Read the full vaccine adjuvants market report here:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Region Currently Holds The Largest Share Of The Vaccine Adjuvants Market?

North America was the largest region in the vaccine adjuvants market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Vaccine Adjuvants Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Browse Through More Reports Similar to the Global Vaccine Adjuvants Market 2026, By The Business Research Company

Vaccine Adjuvants Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Conjugate Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/conjugate-vaccine-global-market-report

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795